We observed prominent induction of several classic YAP/TAZ target genes in prostate cancer, including CTGF, CYR61, and ANKRD1 (Figure 2B), yet this enrichment of YAP/TAZ downstream targets was less striking in the comparisons of breast subsets (Figure 2B; Figure S2). The gene discussed is CCN1; the disease is prostate carcinoma.